The Savior. During the Special Session of the Directing Council of the Pan American Health Organization (PAHO) to address the region’s response to monkeypox, El Salvador and other countries in the region agreed to purchase the vaccine against this disease through the revolving fund of the continental body and that the drug be applied to population groups at risk, in the face of possible contagion.
El Salvador, through the Minister of Health, Francisco Alabi, chaired the aforementioned PAHO meeting, on August 5, in which the subject was addressed with scientific evidence, as well as ensuring the distribution of vaccines to protect the population from monkeypox.
Member countries are on alert for monkeypox, which is already registering cases in some areas of Central America. Apart from El Salvador, Chile, the United States, Argentina, Peru, Brazil, Colombia, Mexico, among others, participated. The current outbreak began in mid-May and has so far affected 89 countries in the world.
The purpose of this special PAHO meeting was to present member states with updated information on the monkeypox outbreak in several countries around the world and to guarantee access to the drug against it.
Minister Alabi reiterated that recent years have been difficult due to infectious diseases. However, “it has been important to be united to face these difficulties.”
Representatives from each nation recognized that there must be timely intervention to control monkeypox in the region; therefore, it is a priority to have the necessary doses to prepare to stop the disease.
Currently, our country does not register any case of monkeypox, but in advance, before the possible entry of cases, El Salvador has already trained technical personnel to deal with possible infections, technical guidelines have been developed and 200 rapid response teams have been trained to boarding. The International Sanitary Offices maintain epidemiological surveillance at the borders.
Source: The Page.
–
